Back to Search
DANIEL HOMMES, M.D.
M.D.
Gastroenterology Physician
NPI: 1891067153Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
SFP000020(CA)
Research & Publications (20)
Risks and benefits of biologic therapy for IBD.
PMID 19300125·J Pediatr Gastroenterol Nutr·2009
8-other
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
PMID 18295023·Lancet·2008
4-observational
Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.
PMID 16507585·Gut·2006
3-trial
The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research.
PMID 15290919·Inflamm Bowel Dis·2004
1-meta
Targeting tumor necrosis factor-alpha in inflammatory bowel disease: why, how, and when?
PMID 15703576·Curr Opin Gastroenterol·2003
8-other
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.
PMID 12477778·Gut·2003
6-review
Infliximab treatment for Crohn's disease: one-year experience in a Dutch academic hospital.
PMID 11854604·Inflamm Bowel Dis·2002
3-trial
Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.
PMID 11781274·Gastroenterology·2002
3-trial
Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease.
PMID 10871234·Curr Opin Clin Nutr Metab Care·2000
6-review
5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.
PMID 19541409·Cancer Lett·2010
8-other
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.
PMID 19637334·Inflamm Bowel Dis·2010
2-rct
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
PMID 19513841·Dig Dis Sci·2010
4-observational
Quality of web-based information on inflammatory bowel diseases.
PMID 19462423·Inflamm Bowel Dis·2009
8-other
Clinical significance of stromal apoptosis in colorectal cancer.
PMID 19654576·Br J Cancer·2009
8-other
Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.
PMID 19462508·Cancer Sci·2009
8-other
5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
PMID 19420017·Carcinogenesis·2009
7-preclinical
Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8.
PMID 19649278·PLoS One·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLZ, SUITE 265
LOS ANGELES, CA 90095 - Phone
- (310) 825-1597
Quick Facts
- NPI
- 1891067153
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile